PDRN decreases the expression of cellular aging markers. by Jingjing Chen (293564)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

“…<p><b>(A)</b> Manhattan plot of minJSW decrease at 24 months. The Manhattan plots show the -log10(P) values of all ~ 1,5 million SNPs against their position. …”

Image 1_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

“…Diagnosing malignant small lung nodules (≤3cm) in CT scans remains a challenge in clinical practice.…”

Image 7_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

“…Diagnosing malignant small lung nodules (≤3cm) in CT scans remains a challenge in clinical practice.…”

Image 6_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

“…Diagnosing malignant small lung nodules (≤3cm) in CT scans remains a challenge in clinical practice.…”

Image 3_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

“…Diagnosing malignant small lung nodules (≤3cm) in CT scans remains a challenge in clinical practice.…”

Image 2_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

“…Diagnosing malignant small lung nodules (≤3cm) in CT scans remains a challenge in clinical practice.…”

Image 4_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

“…Diagnosing malignant small lung nodules (≤3cm) in CT scans remains a challenge in clinical practice.…”

Image 5_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

“…Diagnosing malignant small lung nodules (≤3cm) in CT scans remains a challenge in clinical practice.…”

Image 8_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

“…Diagnosing malignant small lung nodules (≤3cm) in CT scans remains a challenge in clinical practice.…”

K1 expression decreases in HA15 treated cells. by Guillermo Najarro (19964572)

Deep crypt secretory (DCS) cells are predominantly distributed in the proximal colon, with a progressive decrease towards the distal colon. by Daisuke Sugahara (2047696)

Gaussian model fitted of the number of dogs detections of SARS-CoV-2, depending on the cycle threshold (Ct) values of RT-qPCR tests for SARS-CoV-2. by Víctor M. Vidal-Martínez (18707335)

Subjects:

Study 1_CFA1. by Chen-Yueh Chen (9740047)

“…In Study I, a five-phase framework for developing a measurement scale is adopted including items generation, items refinement and edition, exploration of the latent factor structure of the scale and confirmation of reliability, examination of the structure of the factors, and scale validation. …”

Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

Study 1_EFA. by Chen-Yueh Chen (9740047)

“…In Study I, a five-phase framework for developing a measurement scale is adopted including items generation, items refinement and edition, exploration of the latent factor structure of the scale and confirmation of reliability, examination of the structure of the factors, and scale validation. …”

<i>SLC2A2</i> is essential for liver differentiation in developing vertebrates by Yejin Kim (740789)

Subjects:

Study 2_Experiment 1. by Chen-Yueh Chen (9740047)

“…In Study I, a five-phase framework for developing a measurement scale is adopted including items generation, items refinement and edition, exploration of the latent factor structure of the scale and confirmation of reliability, examination of the structure of the factors, and scale validation. …”

Study 1_CFA2. by Chen-Yueh Chen (9740047)

“…In Study I, a five-phase framework for developing a measurement scale is adopted including items generation, items refinement and edition, exploration of the latent factor structure of the scale and confirmation of reliability, examination of the structure of the factors, and scale validation. …”